Clinical Trials Arena on MSN7d
Neurocrine Biosciences initiates trial of VMAT2 inhibitor in healthy adults
Neurocrine Biosciences has commenced the Phase I clinical trial of its oral, small molecule vesicular monoamine transporter 2 ...
The Lancet16d
Feeding dystonia, chorea, psychosis, and self-mutilation in an African patient with neuroacanthocytosis syndrome
A 34-year-old woman with a 2-year history of progressively worsening difficulties in walking, eating and swallowing, presented to our department. The patient's sister reported observing unusual ...
The Lancet16d
Retraction and republication—Feeding dystonia, chorea, psychosis, and self-mutilation in an African patient with neuroacanthocytosis syndrome
The Lancet has discovered that our editorial policies prior to the publication of the Clinical Picture Feeding dystonia, chorea, psychosis, and self-mutilation in an African patient with ...